Rapid identification and susceptibility testing of Candida spp. from positive blood cultures by combination of direct MALDI-TOF mass spectrometry and direct inoculation of Vitek 2

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Idelevich, Evgeny A ^a   Grunewald, Camilla M ^a   Wüllenweber, Jörg ^a   Becker, Karsten ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; VORICONAZOLE; ANTIFUNGAL AGENT;

ANALYTICAL EQUIPMENT; ANALYTICAL ERROR; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLOOD CULTURE; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CONTROLLED STUDY; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; INOCULATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; YEAST CELL; BLOOD; CANDIDIASIS; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA;

ANTIFUNGAL AGENTS; BLOOD; CANDIDA; CANDIDIASIS; HUMANS; MICROBIAL SENSITIVITY TESTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84916919181     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114834     Document Type: Article

References (43)

1. Tortorano AM, Peman J, Bernhardt H, Klingspor L, Kibbler CC, et al. (2004) Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 23:317-322.
2. Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20:133-163.
3. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, et al. (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309-317.
4. Bassetti M, Righi E, Ansaldi F, Merelli M, Cecilia T, et al. (2014) A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med 40:839-845.
5. Kollef M, Micek S, Hampton N, Doherty JA, Kumar A (2012) Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 54:1739-1746.
6. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, et al. (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:e56-e93.
7. Gorton RL, Ramnarain P, Barker K, Stone N, Rattenbury S, et al. (2014) Comparative analysis of Gram's stain, PNA-FISH and Sepsityper with MALDI-TOF MS for the identification of yeast direct from positive blood cultures. Mycoses 57:592-601.
8. Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M (2011) Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Int J Antimicrob Agents 38:65-69.
9. Schmalreck AF, Willinger B, Haase G, Blum G, Lass-Florl C, et al. (2012) Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study. Mycoses 55:e124-e137.
10. Pfaller MA (2012) Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med 125:S3-13.
11. Schmalreck AF, Lackner M, Becker K, Fegeler W, Czaika V, et al. (2014) Phylogenetic relationships matter: antifungal susceptibility among clinically relevant yeasts. Antimicrob Agents Chemother 58:1575-1585.
12. Ferreira L, Sanchez-Juanes F, Porras-Guerra I, Garcia-Garcia MI, Garcia-Sanchez JE, et al. (2011) Microorganisms direct identification from blood culture by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Microbiol Infect 17:546-551.
13. Ferroni A, Suarez S, Beretti JL, Dauphin B, Bille E, et al. (2010) Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 48:1542-1548.
14. Jamal W, Saleem R, Rotimi VO (2013) Rapid identification of pathogens directly from blood culture bottles by Bruker matrix-assisted laser desorption laser ionization-time of flight mass spectrometry versus routine methods. Diagn Microbiol Infect Dis 76:404-408.
15. Nonnemann B, Tvede M, Bjarnsholt T (2013) Identification of pathogenic microorganisms directly from positive blood vials by matrix-assisted laser desorption/ionization time of flight mass spectrometry. APMIS 121:871-877.
16. Spanu T, Posteraro B, Fiori B, D'Inzeo T, Campoli S, et al. (2012) Direct MALDI-TOF mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories. J Clin Microbiol 50:176-179.
17. Yan Y, He Y, Maier T, Quinn C, Shi G, et al. (2011) Improved identification of yeast species directly from positive blood culture media by combining Sepsityper specimen processing and Microflex analysis with the matrix-assisted laser desorption ionization Biotyper system. J Clin Microbiol 49:2528-2532.
18. Idelevich EA, Schüle I, Grünastel B, Wüllenweber J, Peters G, et al. (2014) Rapid identification of microorganisms from positive blood cultures by MALDI-TOF mass spectrometry subsequent to very short-term incubation on solid medium. Clin Microbiol Infect doi: 10.1111/1469-0691.12640.
19. Idelevich EA, Schüle I, Grünastel B, Wüllenweber J, Peters G, et al. (2014) Acceleration of antimicrobial susceptibility testing of positive blood cultures by inoculation of Vitek 2 cards with briefly incubated solid medium cultures. J Clin Microbiol 52:4058-4062.
20. Stevenson LG, Drake SK, Shea YR, Zelazny AM, Murray PR (2010) Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species. J Clin Microbiol 48:3482-3486.
21. bioMérieux SA (2010) VITEK 2 Systems Product Information. 410791. Marcy-l'Etoile, France.
22. ISO (2007) 20776-2. Clinical laboratory testing and in vitro diagnostic test systems - Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 2: Evaluation of performance of antimicrobial susceptibility test devices. International Organization for Standardization. Geneva, Switzerland.
23. FDA (2009) Guidance for industry and FDA - Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) Systems. US Food and Drug Administration, Silver Spring, MD.
24. Buchan BW, Riebe KM, Ledeboer NA (2012) Comparison of the MALDI Biotyper system using Sepsityper specimen processing to routine microbiological methods for identification of bacteria from positive blood culture bottles. J Clin Microbiol 50:346-352.
25. Drancourt M (2010) Detection of microorganisms in blood specimens using matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a review. Clin Microbiol Infect 16:1620-1625.
26. Lavergne RA, Chauvin P, Valentin A, Fillaux J, Roques-Malecaze C, et al. (2013) An extraction method of positive blood cultures for direct identification of Candida species by Vitek MS matrix-assisted laser desorption ionization time of flight mass spectrometry. Med Mycol 51:652-656.
27. Marinach-Patrice C, Fekkar A, Atanasova R, Gomes J, Djamdjian L, et al. (2010) Rapid species diagnosis for invasive candidiasis using mass spectrometry. PLoS One 5:e8862.
28. Dhiman N, Hall L, Wohlfiel SL, Buckwalter SP, Wengenack NL (2011) Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast. J Clin Microbiol 49:1614-1616.
29. Van Herendael BH, Bruynseels P, Bensaid M, Boekhout T, De Baere T, et al. (2012) Validation of a modified algorithm for the identification of yeast isolates using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS). Eur J Clin Microbiol Infect Dis 31:841-848.
30. Buchan BW, Ledeboer NA (2013) Advances in identification of clinical yeast isolates by use of matrixassisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 51:1359-1366.
31. Theel ES, Schmitt BH, Hall L, Cunningham SA, Walchak RC, et al. (2012) Formic acid-based direct, on-plate testing of yeast and Corynebacterium species by Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 50:3093-3095.
32. Bader O, Weig M, Taverne-Ghadwal L, Lugert R, Gross U, et al. (2011) Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect 17:1359-1365.
33. Pinto A, Halliday C, Zahra M, Van HS, Olma T, et al. (2011) Matrix-assisted laser desorption ionizationtime of flight mass spectrometry identification of yeasts is contingent on robust reference spectra. PLoS One 6:e25712.
34. Marklein G, Josten M, Klanke U, Muller E, Horre R, et al. (2009) Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol 47:2912-2917.
35. Cassagne C, Cella AL, Suchon P, Normand AC, Ranque S, et al. (2013) Evaluation of four pretreatment procedures for MALDI-TOF MS yeast identification in the routine clinical laboratory. Med Mycol 51:371-377.
36. Iriart X, Lavergne RA, Fillaux J, Valentin A, Magnaval JF, et al. (2012) Routine identification of medical fungi by the new Vitek MS matrix-assisted laser desorption ionization-time of flight system with a new time-effective strategy. J Clin Microbiol 50:2107-2110.
37. Hamprecht A, Christ S, Oestreicher T, Plum G, Kempf VA, et al. (2014) Performance of two MALDI-TOF MS systems for the identification of yeasts isolated from bloodstream infections and cerebrospinal fluids using a time-saving direct transfer protocol. Med Microbiol Immunol 203:93-99.
38. Kerremans JJ, Goessens WH, Verbrugh HA, Vos MC (2004) Accuracy of identification and susceptibility results by direct inoculation of Vitek 2 cards from positive BACTEC cultures. Eur J Clin Microbiol Infect Dis 23:892-898.
39. Ling TK, Liu ZK, Cheng AF (2003) Evaluation of the VITEK 2 system for rapid direct identification and susceptibility testing of gram-negative bacilli from positive blood cultures. J Clin Microbiol 41:4705-4707.
40. Machen A, Drake T, Wang YF (2014) Same day identification and full panel antimicrobial susceptibility testing of bacteria from positive blood culture bottles made possible by a combined lysis-filtration method with MALDI-TOF VITEK mass spectrometry and the VITEK2 system. PLoS One 9:e87870.
41. Peterson JF, Pfaller MA, Diekema DJ, Rinaldi MG, Riebe KM, et al. (2011) Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp. J Clin Microbiol 49:1765-1771.
42. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG (2007) Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp. J Clin Microbiol 45:3522-3528.
43. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG (2007) Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp. J Clin Microbiol 45:796-802.